Kintor Pharmaceutical Statistics

Total Valuation

HKG:9939 has a market cap or net worth of HKD 529.72 million. The enterprise value is 513.04 million.

Market Cap	529.72M
Enterprise Value	513.04M

Important Dates

The next estimated earnings date is Monday, May 26, 2025.

Earnings Date	May 26, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:9939 has 434.20 million shares outstanding. The number of shares has increased by 0.39% in one year.

Current Share Class	434.20M
Shares Outstanding	434.20M
Shares Change (YoY)	+0.39%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	11.26%
Owned by Institutions (%)	0.20%
Float	360.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	99.56
PB Ratio	1.69
P/TBV Ratio	3.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.10
EV / Sales	96.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.40

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.45.

Current Ratio	1.03
Quick Ratio	0.99
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	-0.66
Interest Coverage	-16.44

Financial Efficiency

Return on equity (ROE) is -41.29% and return on invested capital (ROIC) is -16.74%.

Return on Equity (ROE)	-41.29%
Return on Assets (ROA)	-13.77%
Return on Invested Capital (ROIC)	-16.74%
Return on Capital Employed (ROCE)	-43.77%
Revenue Per Employee	31,672
Profits Per Employee	-983,675
Employee Count	168
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.67% in the last 52 weeks. The beta is -0.12, so HKG:9939's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	+1.67%
50-Day Moving Average	1.23
200-Day Moving Average	1.08
Relative Strength Index (RSI)	49.19
Average Volume (20 Days)	1,270,375

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9939 had revenue of HKD 5.32 million and -165.26 million in losses. Loss per share was -0.38.

Revenue	5.32M
Gross Profit	-5.03M
Operating Income	-162.30M
Pretax Income	-165.24M
Net Income	-165.26M
EBITDA	-148.30M
EBIT	-162.30M
Loss Per Share	-0.38

Full Income Statement

Balance Sheet

The company has 158.23 million in cash and 141.54 million in debt, giving a net cash position of 16.69 million or 0.04 per share.

Cash & Cash Equivalents	158.23M
Total Debt	141.54M
Net Cash	16.69M
Net Cash Per Share	0.04
Equity (Book Value)	312.95M
Book Value Per Share	0.72
Working Capital	5.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -211.86 million and capital expenditures -1.64 million, giving a free cash flow of -213.49 million.

Operating Cash Flow	-211.86M
Capital Expenditures	-1.64M
Free Cash Flow	-213.49M
FCF Per Share	-0.49

Full Cash Flow Statement

Margins

Gross Margin	-94.60%
Operating Margin	-3,050.18%
Pretax Margin	-3,105.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:9939 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.39%
Shareholder Yield	-0.39%
Earnings Yield	-31.20%
FCF Yield	-40.30%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9939 has an Altman Z-Score of -10.43. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.43
Piotroski F-Score	n/a